21602 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
Sub-classes:SUSPENSION CONTAINING RADIOACTIVE MICROSPHERES, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#2Solution Loaded with Alpha-Emitter Radionuclides
#3DISPERSIONS FOR ADDITIVE MANUFACTURING COMPRISING DISCRETE CARBON NANOTUBES
#4RADIOTHERAPY GEL AND METHOD OF PREPARING THE SAME
#5Security mechanisms for radiopharmaceutical elution system and elution process
#6PREPARATIONS OF RADIUM-224 AND PROGENIES FOR USE IN RADIONUCLIDE THERAPY IN COMBINATION WITH DNA REPAIR INHIBITORS
#7Radiotherapy gel and method of preparing the same
#8VISUALIZABLE RADIOACTIVE CARBON MICROSPHERE (CMS), PREPARATION METHOD, AND USE THEREOF
#9RADIOTHERAPY GEL AND METHOD OF PREPARING THE SAME
#10RADIOACTIVE YTTRIUM PHOSPHATE SUSPENSION AND METHOD OF PREPARING THE SAME
#11NOVEL TIN-117M COLLOID FORMULATION WITH THE ABILITY TO DISTINGUISH IT FROM EXISTING TIN-117M COLLOID FORMULATIONS
#12Method of preparing a radioactive yttrium phosphate particle suspension
#13Production of Lu-177 and other radionuclides via hot atom capture on nanostructured carbon
#14Pharmaceutical compositions of sulfur colloid and processes thereof
#15Dispersions for additive manufacturing comprising discrete carbon nanotubes
#16ALPHA PARTICLE FORMULATIONS FOR TREATMENT OF SOLID TUMORS
#17Method of preparing a radioactive yttrium phosphate particle suspension
#18Security mechanisms for radiopharmaceutical elution system and elution process
#19DRUG-IODINATED OIL DISPERSION, METHOD FOR PREPARING SAME AND ITS APPLICATION IN EMBOLIZATION TREATMENT FOR LIVER CANCER
#20COMPOSITION, DEVICE AND METHOD FOR CONFORMATIONAL INTRA-TISSUE BETA BRACHYTHERAPY
#21Probiotic recolonisation therapy
#22PREPARATION OF CARRIER CONTAINING RADIOLABELED COLLOID
#23HYALURONAN SN-117M COLLOID FOR RADIOSYNOVIORTHESIS AND SYMPTOMATIC THERAPY RELATED APPLICATIONS
#24Probiotic recolonisation therapy
#25BIODEGRADABLE MICROSPHERES INCORPORATING RADIONUCLIDES TECHNICAL FIELD
#26Method for labeling exosomes with radioactive substance and use thereof
#27Probiotic recolonisation therapy
#28Probiotic recolonisation therapy
#29Probiotic recolonisation therapy
#30COMPOSITIONS AND METHODS OF TREATING CANCER
#31Composition for Vectorizing an Anti-Cancer Agent
#32Dispersions comprising discrete carbon nanotube fibers
#33Probiotic recolonisation therapy
#34Probiotic recolonisation therapy
#35Probiotic recolonisation therapy
#36Probiotic recolonisation therapy
#37Probiotic recolonisation therapy
#38Probiotic recolonisation therapy
#39Probiotic recolonisation therapy
#40Probiotic recolonisation therapy
#41Chelating amphiphilic polymers
#42Probiotic recolonisation therapy
#43Composition for therapeutic use, including an organic lipid phase and a rare-earth radioisotope complex
#44Particulate Materials And Compositions For Radio Therapy
#45Bioerodible sustained release drug delivery systems
#46Conformally encapsulated multi-electrode arrays with seamless insulation
#47Methods for Treatment of Tumors by Direct Administration of a Radioisotope
#48Particulate materials for radiotherapy and diagnostics
#49Chelating amphiphilic polymers
#50HOMOGENIZATION OF A RADIOPHARMACEUTICAL USING SONIFICATION AND/OR ROTOR-STATOR TECHNOLOGY TO PRODUCE A HOMOGENOUS SUSPENSION, EMULSION, MIXTURE OR SOLID SUSPENSION OF IMMISCIBLE INGREDIENTS
#51RADIOLABELLED MICROPARTICLES, PROCESSES FOR THE PREPARATION THEREOF AND THE USE THEREOF
#52Compositions and methods for treatment of tumors by direct administration of a radioisotope
#53Biocompatible Microbubbles to Deliver Radioactive Compounds to Tumors, Atherosclerotic Plaques, Joints and Other Targeted Sites
#54DIEGHYLENETRIAMINEPENTAACETIC ACID (DTPA)-MODIFIED FERROFLUID, PREPARATION METHOD OF THE SAME AND USES OF THE SAME IN PREPARATION OF PEPTIDE FERROFLUID
#55Linkers for anchoring targeting ligands
#56METHODS OF IMAGING EMPLOYING CHELATING AGENTS
#57Technetium-99m-labeled organic germanium nanocolloids, method of preparing the same and use thereof
#58Pharmaceutical formulations for the prolonged release of active principle(s) and their applications
#59Methods to ameliorate and image angioplasty-induced vascular injury
#60Particulate materials and compositions for radio therapy
#61Stable aqueous colloidal lanthanide oxides
#62Compositions, methods, apparatuses, and systems for singlet oxygen delivery
#63Method for preparing technetium-labeled antimony sulfide nanocolloid
#64Bioerodible sustained release drug delivery systems